ReviewDrugs & aging2016
Optimization of Geriatric Pharmacotherapy: Role of Multifaceted Cooperation in the Hospital Setting.
Review in Drugs & aging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.British journal of clinical pharmacology · 2020Trial
- Article
- The impact of an intervention by a mobile geriatrics team including a pharmacist on potentially inappropriate drug prescription: results of the PharMoG study.BMC geriatrics · 2026Article
- Quality of prescribing and health-related quality of life in older adults: a narrative review with a special focus on patients with atrial fibrillation and multimorbidity.European geriatric medicine · 2025Review
- Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012-2021).International journal of clinical pharmacy · 2024Article
- Guideline-Directed Medical Therapies for Heart Failure with a Reduced Ejection Fraction in Older Adults: A Narrative Review on Efficacy, Safety and Timeliness.Drugs & aging · 2023Review
- The impact of a pharmacist intervention on post-discharge hypnotic drug discontinuation in geriatric inpatients: a before-after study.BMC geriatrics · 2023Article
- Assessment of Knowledge, Attitude and Practices of the Hospital and Community Pharmacists in Saudi Arabia (Jeddah) towards Inappropriate Medication Use in Older Adults.International journal of environmental research and public health · 2023Article
- Patient Interaction Involving Older Adults: Provider vs. Caregiver Expectations.Geriatrics (Basel, Switzerland) · 2022Article
- Article
- Evaluation of two European risk models for predicting medication harm in an Australian patient cohort.European journal of clinical pharmacology · 2022Article
- A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease.Frontiers in pharmacology · 2022Article
- Research status and hotspots of medication safety in older adults: A bibliometric analysis.Frontiers in public health · 2022Review
- The role of pharmacists in geriatric teams: the time is now.European geriatric medicine · 2021Article
- Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches.European geriatric medicine · 2021Review
- Clinical Pharmacy Services in Older Inpatients: An Evidence-Based Review.Drugs & aging · 2020Review
- Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT).BMC geriatrics · 2018Article
- Contribution of Patient Interviews as Part of a Comprehensive Approach to the Identification of Drug-Related Problems on Geriatric Wards.Drugs & aging · 2018Article
- Article
- A case study of polypharmacy management in nine European countries: Implications for change management and implementation.PloS one · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Because older patients are more vulnerable to adverse drug-related events, there is a need to ensure appropriate pharmacotherapy in these patients. This narrative review describes approaches to improve pharmacotherapy in older people in the hospital setting. Screening to identify older patients at risk of drug-related problems and adverse drug reactions (ADRs) is the first critical step within a multistep approach to geriatric pharmacotherapy. Two methods that have been developed are the GerontoNet ADR risk score and the Brighton Adverse Drug Reactions Risk (BADRI) model, which take into account a number of factors, the most important of which is the number of medicines. In order to reduce potentially inappropriate prescribing in older patients, different types of interventions exist, such as pharmacist-led medication reviews, educational interventions, computerized decision support systems, and comprehensive geriatric assessment. The effects of these interventions have been studied, sometimes in a multifaceted approach, by combining different techniques. None of the existing interventions shows a clear beneficial effect on patients' health outcomes if applied in isolation; however, when these interventions are combined within the context of a multidisciplinary team, positive effects on patients' health outcomes can be expected. Appropriate geriatric pharmacotherapy, global assessment of patients' clinical and functional parameters, and integration of skills from different healthcare professionals are needed to address medical complexity of older adults.
Indexed as
Identifiers
26884392What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.